In their analysis of the miRNA profiles of EVs from patients with cirrhosis and HCC, Wang et al. discovered that some elevated miRNAs (miR-122, miR-148a, and miR-1246) were more effective than AFP at differentiating between cirrhosis and HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.